S&P Futures
4,134.75 +10.25 (+0.25%) Dow Futures
32,798.00 +61.00 (+0.19%) Nasdaq Futures
13,079.50 +48.00 (+0.37%) Russell 2000 Futures
1,917.70 +3.10 (+0.16%) Crude Oil
89.05 -1.45 (-1.60%) Gold
1,807.00 -5.30 (-0.29%)
AnPac Bio-Medical Science Co., Ltd. (ANPC)
After hours:
Chart Events
Performance Outlook
| Previous Close | 0.2696 |
| Open | 0.2650 |
| Bid | 0.2476 x 800 |
| Ask | 0.2500 x 2200 |
| Day's Range | 0.2400 - 0.2650 |
| 52 Week Range | 0.2030 - 4.2300 |
| Volume | |
| Avg. Volume | 811,058 |
| Market Cap | 9.721M |
| Beta (5Y Monthly) | 1.32 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.0390 |
| Earnings Date | Sep 29, 2022 - Sep 30, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for ANPC
Related Research
- AnPac Bio-Medical Science Co.,Daily – Vickers Top Insider Picks for 07/15/2022The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.RatingFair ValueEconomic Moat26 days agoArgus Research
- GlobeNewswire
AnPac Bio Announces Appointment of New Directors and Co-Chief Executive Officer
PHILADELPHIA, Aug. 05, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that effective August 2, 2022, the board of directors appointed Jiawen Kang as a member of the board of directors of the Company (the “Board”) and a member of the Audit Committee and Nominating Committee. On that date, the Company also appoi
- GlobeNewswire
AnPac Bio Approved Written Resolutions of a Majority of the Members Addressing the Removal of Directors and Officers, Re-designation of Officers, and Change of Members of the Committees
PHILADELPHIA, July 18, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that the Company’s Members approved Written Resolutions of a Majority of the Members (the “Resolutions”) on July 14, 2022 addressing the removal of directors and officers, re-designation of officers, and change of members of the committees.
- GlobeNewswire
AnPac Bio Regains Compliance with Requirements to Remain Listed on Nasdaq Capital Market
PHILADELPHIA, June 10, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that The Nasdaq Stock Market LLC (“Nasdaq”) notified the Company on June 9, 2022 that Nasdaq has determined the Company has regained compliance with the requirements to remain listed in The Nasdaq Capital Market, as required by a hearing pan
